The objective of this study is to identify determinants for implementing the i-STAT Alinity whole blood traumatic brain injury (TBI) test for its Food and Drug Administration (FDA)-indicated use and to evaluate other potential outcomes with clinical implications. The main questions it aims to answer are: 1. Determine the number of patients with non-elevated (i.e., below clinical cutoff) whole blood iSTAT Alinity tests who also receive CT scans. 2. What are the obstacles for using the i-STAT Alinity for its FDA-indicated use
Objective: The objective of this study is to utilize the integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework to identify determinants for implementing the whole blood traumatic brain injury (TBI) test for its Food and Drug Administration (FDA)-indicated use and to evaluate other potential outcomes with clinical implications. Specific Aims: Aim 1) Evaluate the effectiveness of the whole blood iSTAT Alinity test in determining the need for a head computed tomography (CT) scan in approximately 140 patients with a Glasgow Coma Score (GCS) 13-15 in the emergency department (ED) (approximately 47 per site) while assessing two novel outcomes with significant clinical implications (i.e., reduction in ED length of stay and predictive utility for ED revisits for the same injury). Aim 2) Evaluate determinants for routine use of the whole blood iSTAT Alinity test by assessing acceptability, adoption, appropriateness and feasibility of the test at the organizational- and physician-level for each site and determine how these factors interplay with patient perspectives and knowledge to influence implementation of the test. Aim 3) Develop a site-specific implementation blueprint for use of the whole blood iSTAT Alinity test in determining the need for a head CT scan and pilot test the blueprint in approximately 140 patients with GCS 13-15 in the ED (approximately 47 per site).
Study Type
OBSERVATIONAL
Enrollment
340
The i-STAT TBI cartridge is a point-of-care test that measures the level of biomarkers associated with brain injury in whole blood to help assess patients with suspected mTBI within 24 hours after injury.
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
RECRUITINGRate of CT scans completed
Rate of CTs completed for ED patient participants with a non-elevated i-STAT Alinity whole blood TBI test result.
Time frame: Up to 5 hours (from enrollment to CT scan completion)
ED patient length of stay
Time frame: Up to 5 hours (from arrival to discharge)
Patient return visit to ED
Return visit for same injury within 2 weeks of initial visit
Time frame: Up to two weeks
Military Acute Concussion Evaluation-2 (MACE-2)
MACE 2 is a 15-minute multimodal tool that assists providers in the assessment and diagnosis of concussion. It includes: 1. An unscored screening section collected by clinician interview 2. A cognitive exam with scores ranging 0-30; with higher scores representing better performance. A score of 25 or less is considered abnormal. 3. Normal/Abnormal ratings of neurological function, symptom report, and visual-ocular functioning A total score is not generated.
Time frame: Visit 1 (ED visit)
Neurobehavioral Symptom Inventory (NSI)
The NSI is a 22-item scale of TBI symptoms which takes 2 minutes to complete. Total scores range from 0-88, with higher scores indicating more severe symptom burden.
Time frame: The NSI will be completed once during the patient's visit 1 (ED visit), and once at visit 2 (2-week remote follow-up)
Modified Rosenbaum Concussion Knowledge and Attitudes Survey (RoCKAS)
This is a 13-item survey to evaluate existing knowledge of concussion, which takes 2 minutes to complete. All questions are true/false. Correct responses get one point, with total scores ranging 0-13; higher scores indicate greater knowledge.
Time frame: Visit 1 (ED visit)
Mobilizing Implementation of iPARIHS Facilitation Planning Tool (Mi-PARIHS)
This is a 34-item survey to be filled out by ED providers to identify determinants for implementation of the I-STAT TBI test. Each item is rated with a 5-item likert-scale, rated -2 to +2, to identify barriers and facilitators/enablers for the i-STAT TBI test. Lower scores indicate more barriers.
Time frame: Visit 1 (enrollment) and again at 39 months (study conclusion)
Decisional Conflict Scale (DCS)
The DCS is a 16-item survey about decision-making to be filled out by ED providers. It measures 5 dimensions of decision making, with factors related to feeling uncertain, uninformed, unclear about values, unsupported, or ineffective decision making. All items are scored on a Likert scale ranging from 1 (strongly agree) to 5 (strongly disagree). Total scores range from 16-80; a higher score indicates a higher level of decisional conflict.
Time frame: Visit 1 (enrollment) and again at 39 months (study conclusion)
Implementation Questionnaire
This is a 4-item survey about the i-STAT TBI test implementation to be filled out by ED providers. All items are scored on a Likert scale ranging from 1 (completely disagree) to 5 (completely agree). Total scores range from 4-20; a higher score indicates a higher level of i-STAT TBI test implementation acceptance.
Time frame: Visit 1 (enrollment) and again at 39 months (study conclusion)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.